Lexicon Pharmaceuticals
LXRX
#7142
Rank
A$0.76 B
Marketcap
A$2.11
Share price
-1.41%
Change (1 day)
89.99%
Change (1 year)

Lexicon Pharmaceuticals (LXRX) - Net assets

Net assets on the balance sheet as of September 2025 : A$0.18 Billion

According to Lexicon Pharmaceuticals 's latest financial reports the company has A$0.18 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Lexicon Pharmaceuticals - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$A$0.23 B71.69%
2023-12-31$A$0.13 B-20.6%
2022-12-31$A$0.17 B9.85%
2021-12-31$A$0.15 B-22.95%
2020-12-31$A$0.20 B21.59%
2019-12-31$A$0.16 B-546.23%
2018-12-31$-A$37.49 Million-142.87%
2017-12-31$A$87.44 M-59.96%
2016-12-31$A$0.21 B-44.35%
2015-12-31$A$0.39 B13.07%
2014-12-31$A$0.34 B81.92%
2013-12-31$A$0.19 B-25.66%
2012-12-31$A$0.25 B-11.58%
2011-12-31$A$0.29 B19.34%
2010-12-31$A$0.24 B33.62%
2009-12-31$A$0.18 B-34.43%
2008-12-31$A$0.27 B-15.32%
2007-12-31$A$0.32 B202.21%
2006-12-31$A$0.10 B-7.51%
2005-12-31$A$0.11 B-25.37%
2004-12-31$A$0.15 B-29.73%
2003-12-31$A$0.22 B-25.85%
2002-12-31$A$0.30 B-29.52%
2001-12-31$A$0.42 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Eterna Therapeutics
ERNA
A$5.37 M-97.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
A$46.60 B 25,664.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
A$24.32 M-86.55%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$9.11 B 4,940.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
A$77.01 B 42,471.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-A$0.68 Billion-475.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
A$3.58 B 1,881.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$1.43 B 690.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-A$0.25 Billion-236.47%๐Ÿ‡บ๐Ÿ‡ธ USA